Dried and agglomerated hyaluronic acid product

• US 7,956,180 B2
• Filed: 05/19/2005
• Issued: 06/07/2011
• Est. Priority Date: 05/27/2004
• Status: Expired due to Fees

• Current Assignee: Novozymes Biopharma DK A/S (Novozymes)
• Original Assignee: Novozymes A/S (Novozymes)
• Inventors: Bach, Poul, Thwaites, Eric
• Primary Examiner(s): BLAND, LAYLA D
• Application Number:
  US11/132,829
• Publication Number:
  US 20050267068A1
• Time in Patent Office: 2,210 Days
• Field of Search: None
• US Class Current: 536/55.1
• CPC Class Codes: A61K 31/728 Hyaluronic acid
• CPC Class Codes: A61K 8/735 Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
• CPC Class Codes: A61Q 19/00 Preparations for care of the skin
• CPC Class Codes: A61Q 7/00 Preparations for affecting hair growth
• CPC Class Codes: C08B 37/0072 Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
• CPC Class Codes: C08L 5/08 Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Abstract

The present invention relates to products comprising hyaluronic acid or a salt thereof, which product is dried and agglomerated as defined herein, various compositions and articles comprising the product or compositions of the invention, methods of producing the product of the invention, and uses thereof.

Claims

1. A product comprising a hyaluronic acid or a salt thereof, which product is dried and agglomerated and has:

(a) a moisture content of less than 5%;

(b) a particle size, the 50 percentile of which, is between 180 and 1000 microns, as determined by laser diffraction measurement of the particles suspended in isopropanol;

(c) a dispersibility of less than 30 minutes in an aqueous solvent; and

(d) a solubility of less than 60 minutes in an aqueous solvent;

wherein the hyaluronic acid is not crosslinked and has a molecular weight up to 1,800,000 Da.

2. The product of claim 1, which has a particle size, the 50 percentile of which, is between 200 and 800 microns.

3. The product of claim 1, wherein the hyaluronic acid or salt thereof has a molecular weight in the range of between 10,000 and 1,500,000 Da.

4. The product of claim 1, wherein the hyaluronic acid or salt thereof has an average molecular weight in the range of between 10,000 and 800,000 Da.

5. The product of claim 1, which comprises an inorganic salt of hyaluronic acid.

6. The product of claim 1, wherein the hyaluronic acid or salt thereof has an average molecular weight in the range of 20,000 and 600,000.

7. The product of claim 1, which has a moisture content of less than 2%.

8. The product of claim 1, which has a dispersibility of less than 10 minutes in an aqueous solvent.

9. The product of claim 1, which has a dispersibility of less than 5 minutes in an aqueous solvent.

10. The product of claim 1, which has a solubility of less than 30 minutes in an aqueous solvent.

11. The product of claim 1, which has a solubility of less than 15 minutes in an aqueous solvent.

12. The product of claim 1, which has a solubility of less than 10 minutes in an aqueous solvent.

13. The product of claim 1, which has a solubility of less than 5 minutes in an aqueous solvent.

14. A pharmaceutical composition comprising a product of claim 1 and a pharmaceutically acceptable carrier, excipient or diluent.

15. A pharmaceutical composition comprising a product of claim 1 as a vehicle, and a pharmacologically active agent.

16. A medicament capsule or microcapsule comprising a product of claim 1.

17. A method of producing a product of claim 1, comprising the steps of:

a) drying a product comprising hyaluronic acid or a salt thereof; and

b) agglomerating the dried product.

18. The method of claim 17, wherein the drying step is done using a spray-dryer or a Rotary Atomizer.

19. The method of claim 17, wherein the drying step is done using a Two-Fluid-Nozzle (TFN) spray-dryer.

20. The method of claim 19, wherein the spray-drying was done using a TFN spray-dryer and the following condition ranges:

Inlet temperature;

100-200°

C.,

Outlet temperature;

40-90°

C.,

Nozzle atomization pressure;

2-10 bar,

Nozzle air temperature;

40-100°

C., and

Feed temperature;

40-100°

C.

21. The method of claim 17, wherein the agglomerating step is done using a fluidized bed.

22. The method of claim 21, wherein the fluidized bed inlet temperature is in the range of 30-80°

C., and wherein the aqueous solution of the powder is sprayed on the dried powder at a rate corresponding to an outlet temperature of 25-50°

C.

23. The method of claim 17, wherein the agglomerating step is done using a water-solvent mixture having a water:

solvent ratio of between 0;

100 and 50;

50.

24. The method of claim 23, wherein the solvent is an alcohol.

25. The method of claim 24, wherein the solvent is isopropanol.

26. The method of claim 17, wherein the drying and agglomerating is done in one step using a fluidized spray-dryer.